#TherapyResponse
LightNews LightNews
giuliabiffi.bsky.social
🥳🥳 Very happy to see Eloise Lloyd et al finally published!! 🥳🥳 Congrats to the whole lab! 💜
A beautiful study looking at how distinct #genetics of malignant cells shape #PDACprogression, #MalignantStromalCrosstalk and #TherapyResponse.

#OnlineFirst version👇
aacrjournals.org/cancerres/ar...
SMAD4 and KRAS Status Shape Cancer Cell-Stromal Crosstalk and Therapeutic Response in Pancreatic Cancer
Abstract. Pancreatic ductal adenocarcinoma (PDAC) contains an extensive stroma that modulates response to therapy, contributing to the dismal prognosis associated with this cancer. Evidence suggests t...
aacrjournals.org
January 23, 2025 at 8:39 AM
medcomm.bsky.social
#Letter in @MedComm_MC
Size Matters: Small Circulating Tumor Cells Indicate Worse Therapy Response in Breast Cancer doi.org/10.1002/mco2...

#CellMorphology #CirculatingTumorCells #FlowCytometry #TherapyResponse
November 14, 2025 at 3:45 AM
giuliabiffi.bsky.social
Do you want to know about the impact of #differently #aged #TMEs on #PancreaticCancer malignant cell biology and #TherapyResponse in 🐭 and 👴👵?

Then this study is for you! 😊
February 4, 2026 at 8:27 AM
moloncology.bsky.social
Molecular imaging predicts trastuzumab-deruxtecan (T-DXd) response in head and neck cancer xenograft models

➡️ buff.ly/29qNX19

🖊️ @Muhammadbmirza @EbenRosenthal

#CancerImaging #HNSCC #TherapyResponse
June 6, 2025 at 10:21 AM
bionewscentral.com
Measuring a patient’s absolute #LymphocyteCount can help predict their response to #CARTcelltherapy for #NonHodgkinLymphoma, providing a practical tool to guide #TreatmentDecisions.
#TherapyResponse #ClinicalOutcomes
A routine blood test could help predict who benefits most from CAR T-cell therapy – BioNews Central
Measuring a patient’s absolute lymphocyte count can help predict their response to CAR T-cell therapy for non-Hodgkin lymphoma, providing a practical tool to guide treatment decisions. ...
sbee.link
December 9, 2025 at 4:22 PM
bionewscentral.com
New study reveals why timing of identical #mutations in #ChildhoodLeukemia can produce very different outcomes, opening the door to more precise #therapies.
#BloodCancer #TherapyResponse
Childhood leukemia aggressiveness depends on timing of genetic mutation – BioNews Central
New study reveals why timing of identical mutations in childhood leukemia can produce very different outcomes, opening the door to more precise therapies. ...
sbee.link
December 9, 2025 at 4:08 AM